# Enteral L Citrulline Supplementation in Preterm Infants - Safety, Efficacy and Dosing

> **NCT03649932** · PHASE1 · COMPLETED · sponsor: **The University of Texas Medical Branch, Galveston** · enrollment: 42 (actual)

## Conditions studied

- Bronchopulmonary Dysplasia
- Bronchopulmonary Dysplasia Associated Pulmonary Hypertension
- Pulmonary Hypertension
- Premature Birth
- Chronic Lung Disease of Prematurity

## Interventions

- **DIETARY_SUPPLEMENT:** Enteral L-citrulline

## Key facts

- **NCT ID:** NCT03649932
- **Lead sponsor:** The University of Texas Medical Branch, Galveston
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-25
- **Primary completion:** 2021-06-21
- **Final completion:** 2021-06-21
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2021-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03649932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03649932, "Enteral L Citrulline Supplementation in Preterm Infants - Safety, Efficacy and Dosing". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03649932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*